A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors

Therapeutic monoclonal antibodies (mAbs), targeting tumor antigens, or immune checkpoints, have demonstrated a remarkable anti-tumor effect against various malignancies. However, high costs for mono- or combination therapies, associated with adverse effects or possible development of resistance in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobias, Joshua, Battin, Claire, De Sousa Linhares, Annika, Lebens, Michael, Baier, Karin, Ambroz, Katharina, Drinić, Mirjana, Högler, Sandra, Inic-Kanada, Aleksandra, Garner-Spitzer, Erika, Preusser, Matthias, Kenner, Lukas, Kundi, Michael, Zielinski, Christoph C., Steinberger, Peter, Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266955/
https://www.ncbi.nlm.nih.gov/pubmed/32528470
http://dx.doi.org/10.3389/fimmu.2020.00895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266955/
https://www.ncbi.nlm.nih.gov/pubmed/32528470
http://dx.doi.org/10.3389/fimmu.2020.00895

Ejemplares similares